Shilpa Medicare (SHILPAMED) | Stock Overview & Key Data
Shilpa Medicare Performance Comparison
Stock Range
Today's Range
Low: ₹380.05
High: ₹407.70
on October 3, 2025
52 Week Range
Low: ₹378.05
High: ₹1,000.00
on October 1, 2025
on June 16, 2025
All-Time High: ₹35,595.00 on October 30, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR75.7B
EPS
11.35
P/E Ratio (TTM)
66.36
Forward P/E
18.83
P/B Ratio
3.11
PEG Ratio
0.29
Div. Yield
0.12%
ROE
3.33%
Beta
0.144
Debt to Equity
24.87
Financial Highlights
Profitability
Gross Margin
75.24%
Operating Margin
19.51%
Profit Margin
8.45%
Returns and Earnings
Return on Assets (TTM)
2.36%
Return on Equity (TTM)
3.33%
EBITDA
INR3.4B
Net Income (TTM)
INR1.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR134.51
Quarterly Revenue Growth (YoY)
9.90%
Quarterly Earnings Growth (YoY)
233.40%
Dividend Information
Last 12-Month Dividend
₹1.00
Current Dividend Yield
0.12%
3-Year Average Dividend Yield
0.20%
3-Year Average Annual Dividend
₹0.70
3-Year Total Dividends
₹2.10
Ex-Dividend Date
September 17, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Shilpa Medicare SHILPAMED | 75.74B Mid-cap | -4.13% | -54.21% | -55.51% | -40.76% | -52.37% | -51.47% | 6.46% | -28.53% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | 4.66% | -1.86% | -3.66% | -13.43% | -14.34% | 71.30% | 219.01% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | -4.58% | -6.29% | -16.72% | 2.89% | -5.98% | 5.24% | 52.85% | 79.00% |
| Neuland Laboratories NEULANDLAB | 198.78B Mid-cap | 2.42% | 14.83% | 29.53% | 33.98% | 7.64% | 27.40% | 938.16% | 1,120.48% |
| Alembic APLLTD | 182.09B Mid-cap | -1.73% | -4.07% | -10.65% | 0.83% | -13.79% | -27.24% | 46.45% | -5.63% |
| Jubilant Pharmova JUBLPHARMA | 171.19B Mid-cap | -0.50% | 3.66% | -10.84% | 17.71% | -0.05% | -2.93% | 210.44% | 101.03% |
Ownership & Short Interest
Insider Ownership
57.06%
Institutional Ownership
9.72%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
142K
Average 90-Day Volume
85K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SHILPAMED's 52-week high and low?
- In the last 52 weeks, Shilpa Medicare reached a high of ₹1,000.00 (on June 16, 2025) and a low of ₹378.05 (on October 1, 2025).
- What is the market cap and P/E ratio for SHILPAMED?
- Curious about Shilpa Medicare's size and valuation? Its market capitalization stands at 75.74B. When it comes to valuation, the P/E ratio (trailing twelve months) is 66.36, and the forward P/E (looking ahead) is 18.83.
- Does SHILPAMED pay dividends? If so, what's the yield?
- Yes, Shilpa Medicare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.12%, and the company has paid an average of ₹0.70 per share annually over the past 3 years.
- Who are Shilpa Medicare's main competitors or similar companies to consider before investing?
When looking at Shilpa Medicare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -14.34% 71.30% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 5.24% 52.85% Neuland Laboratories
NEULANDLAB198.78B Healthcare Drug Manufacturers - Specialty & Generic 27.40% 938.16% Alembic
APLLTD182.09B Healthcare Drug Manufacturers - Specialty & Generic -27.24% 46.45% Jubilant Pharmova
JUBLPHARMA171.19B Healthcare Drug Manufacturers - Specialty & Generic -2.93% 210.44% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Shilpa Medicare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Shilpa Medicare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.33%, the Debt to Equity ratio from the most recent quarter is 24.87, and its Gross Profit Margin stands at 75.24%.
- What is the recent revenue and earnings growth for SHILPAMED?
- Looking at Shilpa Medicare's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.90%, and quarterly earnings saw a YoY growth of 233.40%.
- How much of SHILPAMED stock is held by insiders and institutions?
- Wondering who owns Shilpa Medicare stock? Company insiders (like executives and directors) hold about 57.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.72%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.